Galecto Focuses On Oncology And Acquires AML Preclinical Asset
07 Oct 2024 //
GLOBENEWSWIRE
Bridge License Agreement with Cornell University for UBR5 Inhibitor Program
28 Jul 2021 //
PRNEWSWIRE
07 Oct 2024 //
GLOBENEWSWIRE
28 Jul 2021 //
PRNEWSWIRE